Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A 2-year randomized, multicenter, double-blind, placebocontrolled study to determine the efficacy and safety of intravenous zoledronic acid 5 mg administered either annually at randomization and 12 months, or administered at randomization only in the prevention of bone loss in postmenopausal women with osteopenia https://www.kusajili.fr:443/Trial/CFiDTsaIiECx-pLasYYVkQ%24a-2-year-randomized-multicenter-double-blind-placebocontrolled-study-to-determine-the-efficacy-and-safety-of-intravenous-zoledr
I have read and accept the terms of use of the site and the Privacy Policy
Send your message